Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4855707
Max Phase: Preclinical
Molecular Formula: C22H28N6O2
Molecular Weight: 408.51
Molecule Type: Unknown
Associated Items:
ID: ALA4855707
Max Phase: Preclinical
Molecular Formula: C22H28N6O2
Molecular Weight: 408.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCN(C)C(=O)N1C[C@@H]2[C@H](C1)[C@H]2C(=O)N[C@H]1CCN(c2nccc3cccnc23)C1
Standard InChI: InChI=1S/C22H28N6O2/c1-3-26(2)22(30)28-12-16-17(13-28)18(16)21(29)25-15-7-10-27(11-15)20-19-14(6-9-24-20)5-4-8-23-19/h4-6,8-9,15-18H,3,7,10-13H2,1-2H3,(H,25,29)/t15-,16-,17+,18+/m0/s1
Standard InChI Key: QZPQRQJHSMSUIF-WNRNVDISSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 408.51 | Molecular Weight (Monoisotopic): 408.2274 | AlogP: 1.57 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.68 | CX LogP: 0.15 | CX LogD: 0.15 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.83 | Np Likeness Score: -1.28 |
1. Aspnes GE, Menhaji-Klotz E, Boehm M, Londregan AT, Lee ECY, Limberakis C, Coffey SB, Brown JA, Jones RM, Hesp KD.. (2021) Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7., 50 [PMID:34400299] [10.1016/j.bmcl.2021.128320] |
Source(1):